Estradiol valerate/levomefolate

Drug Profile

Estradiol valerate/levomefolate

Alternative Names: BAY 987078

Latest Information Update: 02 Feb 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer HealthCare Pharmaceuticals
  • Class Estradiol congeners; Estrenes; Folic-acids; Hormonal contraceptives; Hormonal replacements; Oral contraceptives; Vitamins
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Pregnancy

Most Recent Events

  • 02 Feb 2015 No development reported - Phase-I for Pregnancy (Prevention) in Germany (PO)
  • 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals
  • 13 Mar 2010 Bayer completes a phase I trial in Contraception/Pregnancy (Prevention) in Germany
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top